Lilly Announces Webcast to Provide Diabetes Portfolio Update at ADA
INDIANAPOLIS, June 11, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will host a webcast on Thursday, July 1, 2021 to discuss the company's diabetes portfolio and its presentations at the American Diabetes Association's Virtual 81st Scientific Sessions. The webcast will begin at 10:00 a.m. Eastern Time and remarks will focus on results from the tirzepatide SURPASS clinical trial program and expected next steps for tirzepatide, as well as Lilly's once-weekly basal insulin and early-phase incretins in people with diabetes.
Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.
About Eli Lilly and Company
Lilly Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about tirzepatide as well as Lilly's once-weekly basal insulin and early-phase incretins and reflects Lilly's current beliefs and expectations. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of research, development, and commercialization. Among other things, there can be no guarantee that the studies will be completed as planned, that future study results will be consistent with the results to date or that medicines will receive regulatory approvals or be commercially successful. For a further discussion of these and other risks and uncertainties, please see Lilly's most recent Form 10-K and Form 10-Q filings with the U.S. Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.
View original content to download multimedia:http://www.prnewswire.com/news-releases/lilly-announces-webcast-to-provide-diabetes-portfolio-update-at-ada-301310953.html
SOURCE Eli Lilly and Company
Company Codes: NYSE:LLY